Uncategorized
FDA approves Actemra for GCA
The FDA has approved Actemra for the treatment of adults with giant cell arteritis. “Rheumatologists will finally have available an option for their patients that is going to allow them to discontinue steroids as rapidly as possible,” Christine Birchwood, PhD, senior medical science director from Genentech, told Healio Rheumatology. “It is the first option these patients will have had in more than 60 years.”